文献速递颅颌面外科

腭裂整复术的挑战与创新:血管化组织增强技术的应用

Cleft Palatoplasty: Challenges and Innovations.
PubMed 文献 · Ann Plast Surg · 2026-07-12

综述探讨腭裂整复术后组织不足、死腔与瘢痕导致腭咽功能不全及上颌生长受限的病理生理机制,并总结颊脂垫瓣、颊肌黏膜瓣等血管化组织增强技术及双侧颊肌黏膜瓣二期腭延长术的应用原理与新兴临床证据。

要点

  • Furlow双反向Z成形术等先进技术广泛采用后,长期结局仍存在差异。
  • 组织不足、死腔和术后瘢痕可削弱腭帆活动度,导致持续性功能障碍。
  • 血管化组织增强技术(颊脂垫瓣、颊肌黏膜瓣)及双侧颊肌黏膜瓣二期腭延长术正日益用于改善结局。

核心结论

  • 血管化组织增强腭整复技术有望减少与组织不足、死腔和瘢痕相关的不良结局,支持其应用的原理与新兴临床证据正在积累。

研究设计与样本

  • 综述:分析腭裂整复术后生长相关不良结局的病理生理机制,并汇总支持血管化组织增强腭整复技术的原理与新兴临床证据。

主要发现

  • Furlow双反向Z成形术等先进技术虽广泛采用,长期结局仍存在差异。
  • 组织不足、死腔和术后瘢痕可削弱腭帆活动度,损害长期腭咽功能。
  • 上颌生长受限可随时间出现,需上颌前移并可导致腭咽功能不全(VPI),进而需要二期言语手术。
  • 颊脂垫瓣、颊肌黏膜瓣等血管化组织增强技术正日益用于加强腭部整复。
  • 双侧颊肌黏膜瓣二期腭延长术治疗VPI已在很大程度上取代咽成形术。

临床怎么用

  • 对腭裂整复后存在组织不足或瘢痕相关腭咽功能不全风险者,可考虑血管化组织增强技术以加强腭部整复。
  • 对需二期腭延长治疗VPI者,双侧颊肌黏膜瓣术式已 largely 取代咽成形术,可作为可选方案。

局限性

  • 原文未报告具体研究设计、样本量、结局数值及统计学指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cleft palatoplasty has evolved substantially in recent decades, with the overarching goal of restoring palatal function for speech while preserving maxillary growth.Despite widespread adoption of advanced techniques such as the Furlow double-opposing Z-plasty, long-term outcomes remain variable. Tissue deficiency, dead space, and postoperative scarring can undermine velar mobility and contribute to persistent dysfunction, ultimately compromising long-term velopharyngeal competence and negating the intended benefits of palatal repair. Additionally, maxillary growth restriction can emerge over time, necessitating maxillary advancement and resulting in velopharyngeal insufficiency (VPI), contributing to the need for secondary speech surgery. In response, innovative, vascularized tissue-augmenting approaches such as buccal fat pad flaps and buccal myomucosal flaps are being increasingly employed to bolster palatal repairs and mitigate factors associated with suboptimal outcomes, as well as secondary palatal lengthening with bilateral buccal myomucosal flaps, for the treatment of VPI has largely replaced pharyngoplasty. This paper examines the pathophysiology of growth-related adverse outcomes following cleft palate repair and presents the rationale, as well as emerging clinical evidence, supporting the use of vascularized tissue-augmenting palatoplasty techniques.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Rogers A, Losee JE, Goldstein JA, et al. Cleft Palatoplasty: Challenges and Innovations. Ann Plast Surg. 2026. PMID: 42442338. doi:10.1097/SAP.0000000000004551

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。